Psychedelic Integration Group

If you’ve had a psychedelic experience that you are struggling to make sense of, this integration group provides an opportunity to explore and understand its impact. In a supportive, confidential, safe space you can share your story and learn from others’ experiences – both positive and negative. The group will be facilitated by psychologists and counsellors with extensive experience of the use of psychedelics within facilitating medical trials and will emphasise how to integrate psychedelic experiences into everyday life in a way that is helpful and meaningful to the individual.
The group discourages active use of psychedelics or other psychoactive drugs during group meetings and, in accordance with the law, neither provides illicit substances nor referrals to illegal psychedelic services or psychedelic psychotherapy.
The group runs on a monthly basis (the second Friday of every month). We ask members to arrive 10 minutes before the start of the group so we can check-in and start on time (late arrival may result in not being able to participate). The group costs £15, please contact us directly if you are unwaged and require a concession rate.
Book tickets here
Dr Rosalind Watts completed her clinical psychology doctoral training at UCL. After six years of practicing psychotherapy she joined the Imperial College Psychedelic Research Group as a therapist ‘trip sitter’. Her research publications include qualitative analysis of participant reports of psilocybin as a treatment for depression. She is currently working alongside Dr. Robin Carhart-Harris and Professor David Nutt planning the next Imperial psilocybin for depression trial.
Michelle is an integrative psychotherapeutic counsellor in private practice, based in London. She is also a member of Imperial college’s psychedelic research team and has been a psychedelic guide on the recent clinical trial studying the efficacy of psilocybin to treat depression. Michelle will also be a lead guide on the upcoming Psilocybin to treat depression RCT with imperial. She also offers individual integration sessions for people who are struggling to process psychedelic experiences.
Greg Donaldson is a transpersonal psychotherapist working in private practice in London and Brighton. He is currently undertaking an MA in psychosynthesis psychotherapy and researching the phenomena of ‘Resistance in the therapy room’. He is deeply interested in psychedelic research and is training to be a psychedelic guide for the upcoming psilocybin trials at Imperial this year. Greg’s interest in sub-personalities and archetypes informs his work with people who are integrating their psychedelic experiences.